Searchable abstracts of presentations at key conferences in endocrinology

ea0032p102 | Bone and Osteoporosis | ECE2013

Effect of long-term valproate therapy on bone health parameters

Jyotsna V P , Singla Rajiv , Singh M B , Suma S V , Gupta Nandita

Introduction: Anti-epileptic drugs (AED) adversely affecting bone health. However, individual variations between different AEDs exist and not all AEDs are equally toxic to the bone. There is almost equipoise about the effect of valproate on bone.Methods: We conducted a cross-sectional study assessing bone mineral density with dual energy X-ray absorptiometry at the hip and lumbar spine in 33 outpatients receiving valproate for ≥1 year and 36 health...

ea0015p14 | Bone | SFEBES2008

Effects of 6 months strontium ranelate administration on phosphocalcium metabolism in postmenopausal women with reduced bone density

Joshi AA , Ahmad AM , Whittingham P , Gupta V , Hamilton A , Durham BH , Fraser WD , Vora JP

Introduction: Strontium ranelate (SR) is a dual action bone agent that increases bone formation and reduces bone resorption. Previous long term studies with SR have demonstrated minimal reductions in parathyroid hormone (PTH) and adjusted calcium (ACa) levels with increase in phosphate (PO4) concentrations, but the exact mechanism of action of SR remains unclear. Postmenopausal women with low bone mineral density (BMD) have relatively high circulating PTH concentrat...